TCIM
AMGN icon

TIAA CREF Investment Management’s Amgen AMGN Stock Holding History

TIAA CREF Investment Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$428M Buy
2,253,965
+200,072
+10% +$38.2M 0.3% 64
2018
Q4 		$400M Sell
2,053,893
-347,424
-14% -$67.8M 0.32% 65
2018
Q3 		$498M Sell
2,401,317
-68,378
-3% -$13.5M 0.33% 65
2018
Q2 		$456M Sell
2,469,695
-411,194
-14% -$72.7M 0.31% 67
2018
Q1 		$491M Sell
2,880,889
-337,854
-10% -$62M 0.33% 65
2017
Q4 		$560M Sell
3,218,743
-116,059
-3% -$20.5M 0.37% 58
2017
Q3 		$622M Sell
3,334,802
-26,006
-0.8% -$4.61M 0.42% 51
2017
Q2 		$579M Sell
3,360,808
-258,903
-7% -$42.1M 0.41% 50
2017
Q1 		$594M Sell
3,619,711
-43,779
-1% -$7.27M 0.43% 48
2016
Q4 		$536M Sell
3,663,490
-474,702
-11% -$71.4M 0.4% 52
2016
Q3 		$690K Sell
4,138,192
-9,975
-0.2% -$1.69M 0.43% 53
2016
Q2 		$631M Sell
4,148,167
-39,348
-0.9% -$6.12M 0.48% 46
2016
Q1 		$628M Sell
4,187,515
-385,284
-8% -$57.2M 0.48% 44
2015
Q4 		$742M Sell
4,572,799
-1,069,715
-19% -$168M 0.56% 34
2015
Q3 		$780M Buy
5,642,514
+1,252,182
+29% +$197M 0.61% 30
2015
Q2 		$674M Sell
4,390,332
-341,448
-7% -$54.7M 0.48% 40
2015
Q1 		$756M Buy
4,731,780
+87,727
+2% +$13.8M 0.53% 36
2014
Q4 		$740M Sell
4,644,053
-9,111
-0.2% -$1.42M 0.52% 37
2014
Q3 		$654M Sell
4,653,164
-7,189
-0.2% -$939K 0.46% 40
2014
Q2 		$552M Sell
4,660,353
-584,715
-11% -$67.7M 0.38% 47
2014
Q1 		$647M Sell
5,245,068
-82,200
-2% -$9.97M 0.47% 39
2013
Q4 		$608M Sell
5,327,268
-581,536
-10% -$66.2M 0.44% 43
2013
Q3 		$661M Sell
5,908,804
-977,146
-14% -$106M 0.52% 37
2013
Q2 		$679M Buy
+6,885,950
New +$715M 0.55% 34

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TIAA CREF Investment Management's AMGN Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Amgen (AMGN) stake by 9.7% in Q1 2019, buying an estimated $38.2M and bringing the position to 2,253,965 shares worth $428M. The position accounts for 0.3% of the portfolio, ranked #64.

TIAA CREF Investment Management first reported a position in AMGN in Q2 2013 and has held it in 24 quarters since. The position peaked at $780M in Q3 2015. 1,886 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • TIAA CREF Investment Management held 2,253,965 shares of Amgen worth $428M as of Q1 2019.
  • TIAA CREF Investment Management bought 200,072 Amgen shares in Q1 2019, an estimated $38.2M.
  • Amgen made up 0.3% of TIAA CREF Investment Management's portfolio in Q1 2019, its #64 holding.
  • TIAA CREF Investment Management first reported a position in Amgen in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Amgen position peaked at $780M in Q3 2015.
  • 1,886 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.